[go: up one dir, main page]

DE60126126D1 - Verwendung mindestens eines aminosulfosäure-derivats in einer zusammensetzung zur förderung der abschuppung der haut - Google Patents

Verwendung mindestens eines aminosulfosäure-derivats in einer zusammensetzung zur förderung der abschuppung der haut

Info

Publication number
DE60126126D1
DE60126126D1 DE60126126T DE60126126T DE60126126D1 DE 60126126 D1 DE60126126 D1 DE 60126126D1 DE 60126126 T DE60126126 T DE 60126126T DE 60126126 T DE60126126 T DE 60126126T DE 60126126 D1 DE60126126 D1 DE 60126126D1
Authority
DE
Germany
Prior art keywords
aminoulic
composition
acid derivative
promote skin
skin removal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60126126T
Other languages
English (en)
Other versions
DE60126126T2 (de
Inventor
Jean-Baptiste Galey
Dominique Bernard
Lucie Simonetti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Publication of DE60126126D1 publication Critical patent/DE60126126D1/de
Application granted granted Critical
Publication of DE60126126T2 publication Critical patent/DE60126126T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DE60126126T 2000-11-17 2001-11-12 Verwendung mindestens eines aminosulfosäure-derivats in einer zusammensetzung zur förderung der abschuppung der haut Expired - Lifetime DE60126126T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0014864A FR2816837A1 (fr) 2000-11-17 2000-11-17 Utilisation d'au moins un derive amino sulfonique dans une composition destinee a favoriser la desquamation de la peau
FR0014864 2000-11-17
PCT/FR2001/003522 WO2002039975A1 (fr) 2000-11-17 2001-11-12 Utilisation d'au moins un derive amino sulfonique dans une composition destinee a favoriser la desquamation de la peau

Publications (2)

Publication Number Publication Date
DE60126126D1 true DE60126126D1 (de) 2007-03-08
DE60126126T2 DE60126126T2 (de) 2007-10-18

Family

ID=8856594

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60126126T Expired - Lifetime DE60126126T2 (de) 2000-11-17 2001-11-12 Verwendung mindestens eines aminosulfosäure-derivats in einer zusammensetzung zur förderung der abschuppung der haut

Country Status (8)

Country Link
US (2) US20030232063A1 (de)
EP (1) EP1337233B1 (de)
JP (2) JP4477300B2 (de)
AU (1) AU2002223057A1 (de)
DE (1) DE60126126T2 (de)
ES (1) ES2280430T3 (de)
FR (1) FR2816837A1 (de)
WO (1) WO2002039975A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0109428D0 (en) * 2001-04-17 2001-06-06 Process & Ind Design Consultan Therapeutic compositions
FR2860716B1 (fr) * 2003-10-13 2005-12-09 Oreal Composition cosmetique comprenant un hydroxyacide, un polyholoside et un compose amino-sulfonique
FR2864784B1 (fr) * 2004-01-06 2006-02-10 Oreal Composition cosmetique comprenant un organopolysiloxane elastomere et un compose amino-sulfonique
FR2884712B1 (fr) * 2005-04-21 2007-06-15 Oreal Compositions cosmetiques comprenant des derives de piperazine
FR2888494B1 (fr) * 2005-07-13 2014-03-14 Oreal Utilisation de composes d'uree pour favoriser la desquamation
US7999008B2 (en) 2005-07-13 2011-08-16 L'oreal Urea compounds that promote desquamation
US20070253988A1 (en) * 2006-04-27 2007-11-01 L'oreal Methods for peeling skin
US20080050334A1 (en) * 2006-08-24 2008-02-28 L'oreal Cosmetic composition comprising an extract of emblica officinalis, a hydroxy acid, and an N-substituted aminosulfonic acid, and methods of using same
EP2326619B1 (de) * 2008-08-01 2019-02-27 Bioxiness Pharmaceuticals, Inc. Methioninanaloga und verfahren zu deren anwendung
RU2724055C2 (ru) 2015-12-31 2020-06-19 Колгейт-Палмолив Компани Очищающие композиции
MX375849B (es) 2016-08-19 2025-03-07 Unilever Ip Holdings B V Una composicion antimicrobiana
CN109640930B (zh) 2016-08-19 2021-11-26 联合利华知识产权控股有限公司 抗微生物组合物
EP4456866A1 (de) * 2021-12-29 2024-11-06 L'oreal Kosmetische zusammensetzung zur pflege der haut

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1206097A (en) * 1982-08-17 1986-06-17 Donncha O'sullivan Pharmaceutical composition
FR2581542B1 (fr) * 1985-05-07 1988-02-19 Oreal Compositions topiques destinees au traitement de la peau a base de derives de l'acide salicylique
GB8713091D0 (en) * 1987-06-04 1987-07-08 Millrine W P Pharmaceutical compositions
US5256660A (en) * 1987-12-14 1993-10-26 Henry Swan Ii Trust Synthetic buffer composition for clinical use
AU641529B2 (en) * 1990-07-30 1993-09-23 Bloomfield D.A. Zwitterionic compounds and their N-halo derivatives for use in the treatment of clinical conditions
JPH06116151A (ja) * 1991-08-06 1994-04-26 Asahi Chem Ind Co Ltd 増殖性皮膚疾患治療用組成物
FR2714831B1 (fr) * 1994-01-10 1996-02-02 Oreal Composition cosmétique et/ou dermatologique contenant des dérivés d'acide salicylique et procédé de solubilisation de ces dérivés.
US5420106A (en) * 1994-03-22 1995-05-30 Bristol-Myers Squibb Company Method and composition having enhanced alpha-hydroxy acid skin permeation and retention
WO1996021421A1 (fr) * 1995-01-09 1996-07-18 Soc D Expl Francaise Des Rech Milieu nutritif utilisable comme milieu de culture de cellules epidermiques et applications
WO1996023490A1 (en) * 1995-02-03 1996-08-08 Cosmederm Technologies Formulations and methods for reducing skin irritation
FR2738484B1 (fr) * 1995-09-07 1997-10-03 Oreal Utilisation de l'acide cysteique ou homocysteique pour favoriser la desquamation de la peau ou stimuler le renouvellement epidermique
TW508247B (en) * 1997-03-31 2002-11-01 Shiseido Co Ltd Cosmetic or dermatological topical composition
EP1033913A1 (de) * 1997-11-28 2000-09-13 Peter T. Pugliese Zwitterionische fettsäure-verbindungen zur entzündungshemmung
FR2782922B1 (fr) * 1998-09-09 2002-07-19 Oreal Composition contenant de l'uree et ses utilisations dans le domaine cosmetique et/ou dermatologique

Also Published As

Publication number Publication date
US20030232063A1 (en) 2003-12-18
ES2280430T3 (es) 2007-09-16
US20070134183A1 (en) 2007-06-14
JP2006232858A (ja) 2006-09-07
EP1337233A1 (de) 2003-08-27
JP4477300B2 (ja) 2010-06-09
AU2002223057A1 (en) 2002-05-27
DE60126126T2 (de) 2007-10-18
FR2816837A1 (fr) 2002-05-24
JP2004513911A (ja) 2004-05-13
WO2002039975A1 (fr) 2002-05-23
EP1337233B1 (de) 2007-01-17

Similar Documents

Publication Publication Date Title
DE60126126D1 (de) Verwendung mindestens eines aminosulfosäure-derivats in einer zusammensetzung zur förderung der abschuppung der haut
DE60322101D1 (de) Zusammensetzungzur herstellung zur äusserlichen anwendung auf der haut sowie verfahren zu ihrer verwendung
DE60117115D1 (de) Schnappanordnung zur lösbaren Befestigung eines Gegenstandes an mindestens einer Leitung
DE60040852D1 (de) Einwegwerftuch zum wischen sowie verfahren zur herstellung desselben
DE60117181D1 (de) Insektenvetreibende aerosolzusammensetzung mit niedrigem voc-gehalt und verfahren zum anbringen auf die haut
DE60124133D1 (de) Verbesserung eines lanzettengeräts zum punktieren der haut
DK1390014T3 (da) Sammensætning til anvendelse i en fremgangsmåde til behandling af hyperplasi
EE200300103A (et) Kontratseptsioonimeetod ja kontratseptiivi manustatav vorm
DE60108184D1 (de) Verfahren zur Herstellung von Fettsäureestern
DE69912757D1 (de) Verwendung eines zusatzes in einer brennstoffzusammensetzung
DE60127012D1 (de) Verfahren zur Herstellung einer photonischen Kristallstruktur
DE60105389D1 (de) Insektenvertreibende zusammensetzung mit verlängerter wirkungsdauer und verfahren zum anbringen auf die haut
DE69900052D1 (de) Feste form- oder knetbare Zusammensetzung erwärmbar durch Befeuchtung zur Pflege und Reinigung der Haut
EE05215B1 (et) Meetod tskloproplkarbokslhappe estrite ja derivaatide valmistamiseks
DE60107987D1 (de) Verfahren zur Herstellung von Acrolein und Acrylsäure
ATE401309T1 (de) Verwendung von 2-fuoro-3-ketoestern zur herstellung von 3-fuoro-6,7,8,9-tetrahydro-4h- pyrimidoä1,2-aüpyrimidin-4-onen
DE60029308D1 (de) Mit einer haut versehenen hohlfersermembran und verfahren zur herstellung
DE60129597D1 (de) Verfahren zur verbesserung der stabilität einer pharmazeutischen zubereitung
DE60104367D1 (de) Verfahren zur Herstellung von Titan-haltigen wässrigen Lösungen
EE200100514A (et) LFA-1 ICAM-idega seondumise inhibiitorid ja nendekasutamine
DE60229460D1 (de) Verwendung von einem Diamidderivat in einer kosmetischen Zusammensetzung für die Haut
DE60214168D1 (de) Verfahren zur herstellung einer in hohem grade linearen alkoholzusammensetzung
DE60100858D1 (de) Prozess zur herstellung der kristallinen form i von cabergolin
DE602005009862D1 (de) Verfahren zur herstellung eines papillengewebes der haut mit haarfollikelinduktionspotential
DE60139266D1 (de) Herstellungsverfahren und verwendung von tetrahydrocurcuminoiden zur regulierung der physiologischen und pathologischen fälle in der haut und in den schleimhautzellen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition